Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Volz

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 19, 2022
Effect of anxiolytic drug silexan on sleep - a narrative reviewErich Seifritz, Siegfried Kasper, Hans-Jürgen Möller, et al.
International Clinical Psychopharmacology|June 24, 2010
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depressionSiegfried Kasper, Markus Gastpar, Hans-Juergen Möller, et al.
The International Journal of Neuropsychopharmacology|January 25, 2014
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetineSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 1, 2024
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trialSiegfried Kasper, Hans-Peter Volz, Hans-Jürgen Möller, et al.
Wiener Medizinische Wochenschrift (1946)|December 21, 2010
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trialsSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
International Clinical Psychopharmacology|June 1, 2010
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trialSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
Neuroimage|February 6, 2007
Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophreniaStefan Smesny, Timm Rosburg, Igor Nenadic, et al.
Journal of Psychiatric Research|November 22, 2020
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteersHans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, et al.
The International Journal of Neuropsychopharmacology|December 10, 2020
No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled TrialErich Seifritz, Hans-Jürgen Möller, Hans-Peter Volz, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 4, 2009
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severityAndreas B Schmitt, Michael Bauer, Hans-Peter Volz, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 19, 2022
Effect of anxiolytic drug silexan on sleep - a narrative reviewErich Seifritz, Siegfried Kasper, Hans-Jürgen Möller, et al.
International Clinical Psychopharmacology|June 24, 2010
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depressionSiegfried Kasper, Markus Gastpar, Hans-Juergen Möller, et al.
The International Journal of Neuropsychopharmacology|January 25, 2014
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetineSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 1, 2024
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trialSiegfried Kasper, Hans-Peter Volz, Hans-Jürgen Möller, et al.
Wiener Medizinische Wochenschrift (1946)|December 21, 2010
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trialsSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
International Clinical Psychopharmacology|June 1, 2010
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trialSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
Neuroimage|February 6, 2007
Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophreniaStefan Smesny, Timm Rosburg, Igor Nenadic, et al.
Journal of Psychiatric Research|November 22, 2020
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteersHans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, et al.
The International Journal of Neuropsychopharmacology|December 10, 2020
No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled TrialErich Seifritz, Hans-Jürgen Möller, Hans-Peter Volz, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 4, 2009
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severityAndreas B Schmitt, Michael Bauer, Hans-Peter Volz, et al.
Pageof 5